Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis

被引:12
作者
Min, Se Hee [1 ]
Phung, Anita [2 ]
Oh, Tae Jung [1 ]
Han, Kyou-Sup [3 ]
Kim, Man Jin [3 ]
Kim, Jee Min [1 ]
Lee, Ji Hyun [1 ]
Park, Young Joo [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 03080, South Korea
[2] Kings Coll London, Sch Med, London WC2R 2LS, England
[3] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea
关键词
Plasmapheresis; Graves Disease; Thyrotoxicosis; PLASMA-EXCHANGE; GRAVES-DISEASE; MANAGEMENT; LITHIUM;
D O I
10.3346/jkms.2015.30.10.1531
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Therapeutic plasma exchange (TPE) is one possible treatment for patients resistant to conventional antithyroid drugs or requiring urgent attention for thyrotoxicosis. We report a 35-yr-old man with thyrotoxicosis, ultimately attributed to Graves' disease in whom antithyroid drug used initially was soon discontinued, due to abnormal liver function, and replaced by Lugol's solution. Three weeks later, an escape phenomenon (to Lugol's solution) was apparent, so we performed TPE to control the thyrotoxicosis. Two courses of TPE by a centrifugal type machine resulted in diminished levels of thyroid hormone levels, which then rebounded after another two courses of membrane filtration type TPE. However, the patient could be treated with radioactive iodine therapy without any complications at present.
引用
收藏
页码:1531 / 1534
页数:4
相关论文
共 50 条
  • [41] Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment
    Liu, Xiaodong
    Wong, Carlos K. H.
    Chan, Wendy W. L.
    Tang, Eric H. M.
    Woo, Yu Cho
    Lam, Cindy L. K.
    Lang, Brian H. H.
    ANNALS OF SURGERY, 2021, 273 (06) : 1197 - 1206
  • [42] Outcome and Incidence of Hypothyroidism in Low-dose Radioactive Iodine Treatment for Hyperthyroidism
    Lin, K. -h.
    Wu, J. -c.
    Wu, M. -c.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2025, 44 (02):
  • [43] Patient Perspectives on the Extent of Surgery and Radioactive Iodine Treatment for Low-Risk Differentiated Thyroid Cancer
    Lubitz, Carrie C.
    Kiernan, Colleen M.
    Toumi, Asmae
    Zhan, Tiannan
    Roth, Mara Y.
    Sosa, Julie A.
    Tuttle, R. Michael
    Grubbs, Elizabeth G.
    ENDOCRINE PRACTICE, 2021, 27 (05) : 383 - 389
  • [44] Histologic Findings and Cytological Alterations in Thyroid Nodules After Radioactive Iodine Treatment for Graves' Disease: A Diagnostic Dilemma
    El Hussein, Siba
    Omarzai, Yumna
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2017, 25 (04) : 314 - 318
  • [45] Gastric damage related to radioactive iodine treatment and the protective effect of amifostine.
    Sezer, Atakan
    Celik, Mehmet
    Usta, Ufuk
    Altun, Gulay Durmus
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (08): : 3705 - 3710
  • [46] Radioactive iodine treatment for differentiated thyroid carcinoma in Japan
    Okamoto, Takahiro
    SURGERY, 2010, 147 (03) : 432 - 433
  • [47] EARLY TISSUE DISTRIBUTION OF THERAPEUTIC I-131 IN A PATIENT WITH THYROTOXICOSIS
    VACHAL, E
    WEGST, A
    PRESTON, D
    TOMITA, T
    JOURNAL OF SURGICAL ONCOLOGY, 1979, 11 (04) : 283 - 288
  • [48] Effectiveness of radioactive iodine (131I) in the treatment of Graves' disease: single center experience in Assiut University hospital
    Mohamadien, Nsreen R. A.
    Sayed, Mohamed H. M.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 10 (05): : 235 - 242
  • [49] Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis
    Stefanutti, C.
    Di Giacomo, S.
    Labbadia, G.
    TRANSFUSION AND APHERESIS SCIENCE, 2011, 45 (01) : 3 - 7
  • [50] Graves Ophthalmopathy After Treatment of Subclinical Hyperthyroidism From Multinodular Goiter With Radioactive Iodine
    Signore, Christine
    ENDOCRINOLOGIST, 2010, 20 (04) : 157 - 159